Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2011
Adjuvant chemoradiation after laparoscopically assisted vaginal radical hysterectomy (LARVH) in patients with cervical cancer: oncologic outcome and morbidityArne Gruen, Thabea Musik, Christhardt Köhler, et al.
Radiation Oncology (London, England)|July 6, 2010
Intensity-modulated radiotherapy in patients with cervical cancer. An intra-individual comparison of prone and supine positioningCarmen Stromberger, Yves Kom, Michael Kawgan-Kagan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2010
Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicitySimone Marnitz, Carmen Stromberger, Michael Kawgan-Kagan, et al.
In Vivo (Athens, Greece)|February 24, 2021
Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysisMoonef Alotaibi, Valeria Valova, Toni HÄnsel, et al.
Cancers|October 13, 2021
Risks and Benefits of Fiducial Marker Placement in Tumor Lesions for Robotic Radiosurgery: Technical Outcomes of 357 ImplantationsMelina Kord, Anne Kluge, Markus Kufeld, et al.
Radiation Oncology (London, England)|March 17, 2021
Radiotherapeutic treatment options for oligotopic malignant liver lesionsPeter Wust, Marcus Beck, Robert Dabrowski, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 8, 2016
Unilateral and bilateral neck SIB for head and neck cancer patients : Intensity-modulated proton therapy, tomotherapy, and RapidArcCarmen Stromberger, Luca Cozzi, Volker Budach, et al.
Cancers|March 29, 2023
Subgroup Analysis of Overall Survival among Smoking and Non-Smoking Elderly Patients with HNSCCRaphaela Graessle, Carmen Stromberger, Marcus Beck, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2015
Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trialVolker Budach, Carmen Stromberger, Christoph Poettgen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 15, 2019
Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapyAlexandra Hochreiter, Jacqueline R Kelly, Melissa Rasar Young, et al.
Pageof 7